RAB39A

Ras-related protein Rab-39A · Q14964 · RAB39A on Sugi Atlas →

0 patent compounds predicted against RAB39A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RAB39A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
Identification of New Biomarkers of Insulin Resistance nanACTIVE_NOT_RECRUITING
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial nanRECRUITING
Fox BioNet Project: LRRK2-002 nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Parkinson's Families Project nanRECRUITING
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) nanCOMPLETED
Gene Analysis of Parkinson's Disease nanCOMPLETED
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder nanUNKNOWN
RASopathy Biorepository nanRECRUITING
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort nanRECRUITING
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Study of Chediak-Higashi Syndrome nanRECRUITING
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients nanCOMPLETED
Familial Aggregation and Biomarkers in REM Sleep Behaviour Disorder. nanUNKNOWN
Pubertal Development in Patients with RASopathies nanRECRUITING
Registry and Natural History of Epilepsy-Dyskinesia Syndromes nanRECRUITING
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients nanRECRUITING
Genetic Studies of Chronic Active Epstein-Barr Disease nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RAB39A binder may also engage these)

ProteinNameSimilarity
Q8BHD0 1.000 Q8BHD0 →
Q8BHC1 1.000 Q8BHC1 →
Q17QU4 1.000 Q17QU4 →
Q68EK7 1.000 Q68EK7 →
F1PTE3 0.999 F1PTE3 →
A0A125YY17 0.999 A0A125YY17 →
Q15771 0.998 Q15771 →
Q923S9 0.998 Q923S9 →
P36410 0.998 P36410 →
P61017 0.998 P61017 →
Q5KTJ7 0.998 Q5KTJ7 →
Q96DA2 0.998 Q96DA2 →
P25228 0.998 P25228 →
Q54DA7 0.998 Q54DA7 →
P20337 0.998 P20337 →
Q18969 0.997 Q18969 →
P35286 0.997 P35286 →
P35281 0.997 P35281 →
Q9UL26 0.997 Q9UL26 →
P61018 0.997 P61018 →
P63011 0.996 P63011 →
Q0WQN4 0.996 Q0WQN4 →
Q96E17 0.996 Q96E17 →
P62823 0.996 P62823 →
Q17QB7 0.996 Q17QB7 →
P16976 0.996 P16976 →
P93267 0.996 P93267 →
Q86YS6 0.996 Q86YS6 →
P11023 0.996 P11023 →
Q5ZLG1 0.996 Q5ZLG1 →